Gilead Sciences (GILD)

Nasdaq Health Care Biotechnology S&P 500Nasdaq-100

$166.89

-0.68 (-0.41%)

Close of Nov 06, 2026 · end-of-day data

Source: Gilead Sciences's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$30.39B	$26.11B	$22.13B	$22.45B	$24.69B	$27.30B	$27.28B	$27.12B	$28.75B	$29.44B
Cost of revenue	$4.26B	$4.37B	$4.85B	$4.67B	$4.57B	$6.60B	$5.66B	$6.50B	$6.25B	$6.23B
Gross profit	$26.13B	$21.74B	$17.27B	$17.77B	$20.12B	$20.70B	$21.62B	$20.62B	$22.50B	$23.21B
Research & development	$5.10B	$3.73B	$5.02B	$9.11B	$4.93B	$4.60B	$4.98B	$5.72B	$5.91B	$5.80B
Selling, general & admin	$3.40B	$3.88B	$4.06B	$4.38B	$5.15B	$5.25B	$5.67B	$6.09B	$6.09B	$5.77B
Operating income	$17.63B	$14.12B	$8.20B	$4.29B	$4.07B	$9.92B	$7.33B	$7.61B	$1.66B	$10.02B
Interest expense	$964.00M	$1.12B	$1.08B	$995.00M	$984.00M	$1.00B	$935.00M	$944.00M	$977.00M	$1.02B
Pre-tax income	$17.10B	$13.53B	$7.80B	$5.16B	$1.67B	$8.28B	$5.81B	$6.86B	$690.00M	$9.80B
Income tax	$3.61B	$8.88B	$2.34B	-$204.00M	$1.58B	$2.08B	$1.25B	$1.25B	$211.00M	$1.29B
Net income	$13.50B	$4.63B	$5.46B	$5.39B	$123.00M	$6.22B	$4.59B	$5.67B	$480.00M	$8.51B
EBITDA	$17.81B	$14.36B	$8.43B	$4.54B	$4.36B	$10.25B	$7.65B	$7.96B	$2.04B	$10.39B
EPS (basic)	$10.08	$3.54	$4.20	$4.24	$0.10	$4.96	$3.66	$4.54	$0.38	$6.84
EPS (diluted)	$9.94	$3.51	$4.17	$4.22	$0.10	$4.93	$3.64	$4.50	$0.38	$6.78
Diluted shares	1.36B	1.32B	1.31B	1.28B	1.26B	1.26B	1.26B	1.26B	1.25B	1.25B
Gross margin	86.0%	83.3%	78.1%	79.2%	81.5%	75.8%	79.3%	76.0%	78.3%	78.8%
Operating margin	58.0%	54.1%	37.1%	19.1%	16.5%	36.3%	26.9%	28.0%	5.8%	34.0%
Net margin	44.4%	17.7%	24.7%	24.0%	0.5%	22.8%	16.8%	20.9%	1.7%	28.9%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$8.23B	$7.59B	$17.94B	$11.63B	$6.00B	$5.34B	$5.41B	$6.08B	$9.99B	$7.56B
Short-term investments	$3.67B	$17.92B	$12.15B	$12.72B	$1.41B	$1.18B	$973.00M	$1.18B	$0	$68.00M
Receivables	$4.51B	$3.85B	$3.33B	$3.58B	$4.89B	$4.49B	$4.78B	$4.66B	$4.42B	$4.91B
Inventory	$1.59B	$801.00M	$814.00M	$922.00M	$1.68B	$1.62B	$1.51B	$1.79B	$1.71B	$1.77B
Total current assets	$19.59B	$31.82B	$35.84B	$30.30B	$16.00B	$14.77B	$14.44B	$16.09B	$19.17B	$18.34B
Goodwill	$1.17B	$4.16B	$4.12B	$4.12B	$8.11B	$8.33B	$8.31B	$8.31B	$8.31B	$8.31B
Total assets	$56.98B	$70.28B	$63.67B	$61.63B	$68.41B	$67.95B	$63.17B	$62.12B	$58.99B	$59.02B
Total current liabilities	$9.22B	$11.63B	$10.61B	$9.76B	$11.40B	$11.61B	$11.24B	$11.28B	$12.00B	$11.81B
Short-term debt	$0	$2.75B	$2.75B	$2.50B	$2.76B	$1.52B	$2.27B	$1.80B	$1.81B	$2.81B
Long-term debt	$26.35B	$30.80B	$24.57B	$22.09B	$28.64B	$25.18B	$22.96B	$23.19B	$24.90B	$22.13B
Total debt	$26.35B	$33.54B	$27.32B	$24.59B	$31.40B	$26.70B	$25.23B	$24.99B	$26.71B	$24.94B
Total liabilities	$38.09B	$49.84B	$42.29B	$39.10B	$50.20B	$46.88B	$41.93B	$39.29B	$39.66B	$36.32B
Shareholders' equity	$18.89B	$20.44B	$21.39B	$22.52B	$18.20B	$21.07B	$21.24B	$22.83B	$19.33B	$22.70B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$17.05B	$11.90B	$8.40B	$9.14B	$8.17B	$11.38B	$9.07B	$8.01B	$10.83B	$10.02B
Capital expenditures	$748.00M	$590.00M	$924.00M	$825.00M	$650.00M	$579.00M	$728.00M	$585.00M	$523.00M	$563.00M
Free cash flow	$16.30B	$11.31B	$7.48B	$8.32B	$7.52B	$10.80B	$8.34B	$7.42B	$10.30B	$9.46B
Investing cash flow	-$11.98B	-$16.07B	$14.36B	-$7.82B	-$14.62B	-$3.13B	-$2.47B	-$2.27B	-$3.45B	-$4.79B
Financing cash flow	-$9.72B	$3.39B	-$12.32B	-$7.63B	$770.00M	-$8.88B	-$6.47B	-$5.12B	-$3.43B	-$7.75B
Dividends paid	$2.46B	$2.73B	$2.97B	$3.22B	$3.45B	$3.60B	$3.71B	$3.81B	$3.92B	$4.00B
Share buybacks	$11.00B	$954.00M	$2.90B	$1.75B	$1.58B	$546.00M	$1.40B	$1.00B	$1.15B	$1.92B
Stock-based compensation	$380.00M	$638.00M	$845.00M	$636.00M	$643.00M	$635.00M	$637.00M	$766.00M	$835.00M	$894.00M
Depreciation & amortization	$177.00M	$233.00M	$226.00M	$255.00M	$288.00M	$329.00M	$323.00M	$354.00M	$381.00M	$370.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$7.11B	$6.69B	$6.95B	$7.54B	$7.57B	$6.67B	$7.08B	$7.77B	$7.92B	$6.96B	$7.80B	$8.30B
Cost of revenue	$2.09B	$1.55B	$1.54B	$1.57B	$1.58B	$1.54B	$1.50B	$1.57B	$1.62B	$1.45B	$1.58B	$1.57B
Gross profit	$5.02B	$5.13B	$5.41B	$5.97B	$5.99B	$5.13B	$5.58B	$6.20B	$6.30B	$5.51B	$6.22B	$6.73B
Research & development	$1.41B	$1.52B	$1.35B	$1.40B	$1.64B	$1.38B	$1.49B	$1.35B	$1.58B	$1.37B	$1.76B	$1.61B
Selling, general & admin	$1.61B	$1.38B	$1.38B	$1.43B	$1.91B	$1.26B	$1.36B	$1.36B	$1.79B	$1.45B	$1.92B	$1.64B
Operating income	$1.61B	-$4.32B	$2.64B	$888.00M	$2.45B	$2.24B	$2.47B	$3.33B	$1.98B	$2.59B	-$10.39B	$3.46B
Interest expense	$252.00M	$254.00M	$237.00M	$238.00M	$249.00M	$260.00M	$254.00M	$256.00M	$255.00M	$240.00M	$247.00M	$269.00M
Pre-tax income	$1.65B	-$4.49B	$2.05B	$956.00M	$2.17B	$1.65B	$2.43B	$3.64B	$2.08B	$2.58B	-$10.25B	$3.06B
Income tax	$237.00M	-$315.00M	$438.00M	-$297.00M	$385.00M	$334.00M	$468.00M	$589.00M	-$105.00M	$559.00M	$242.00M	$634.00M
Net income	$1.43B	-$4.17B	$1.61B	$1.25B	$1.78B	$1.31B	$1.96B	$3.05B	$2.18B	$2.02B	-$10.50B	$2.43B
EBITDA	$1.70B	-$4.23B	$2.74B	$982.00M	$2.55B	$2.33B	$2.57B	$3.42B	$2.07B	$2.68B	-$10.30B	$3.59B
EPS (basic)	$1.15	$-3.34	$1.29	$1.00	$1.42	$1.06	$1.57	$2.46	$1.76	$1.63	$-8.45	$1.96
EPS (diluted)	$1.13	$-3.34	$1.29	$1.00	$1.42	$1.04	$1.56	$2.43	$1.74	$1.61	$-8.45	$1.94
Diluted shares	-1.00M	1.25B	1.25B	1.25B	8.00M	1.26B	1.25B	1.25B	-1.00M	1.25B	1.24B	1.25B
Gross margin	70.6%	76.8%	77.8%	79.1%	79.1%	76.9%	78.8%	79.8%	79.5%	79.2%	79.8%	81.1%
Operating margin	22.7%	-64.6%	38.0%	11.8%	32.4%	33.6%	34.9%	42.8%	25.0%	37.2%	-133.2%	41.7%
Net margin	20.1%	-62.4%	23.2%	16.6%	23.6%	19.7%	27.7%	39.3%	27.5%	29.0%	-134.5%	29.3%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$6.08B	$4.72B	$2.77B	$5.04B	$9.99B	$7.93B	$5.14B	$7.33B	$7.56B	$7.63B	$3.18B	$6.44B
Short-term investments	$1.18B	$0	$0	$0	$0	—	$69.00M	$19.00M	$68.00M	$15.00M	$0	$0
Receivables	$4.66B	$4.67B	$4.66B	$4.59B	$4.42B	$4.39B	$4.78B	$5.09B	$4.91B	$4.74B	$5.05B	$5.01B
Inventory	$1.79B	$1.85B	$2.03B	$1.87B	$1.71B	$1.76B	$1.82B	$1.78B	$1.77B	$1.91B	$1.95B	$1.90B
Total current assets	$16.09B	$14.04B	$12.32B	$14.78B	$19.17B	$16.90B	$14.72B	$17.87B	$18.34B	$18.64B	$13.95B	$16.55B
Goodwill	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B	$8.31B
Total assets	$62.12B	$56.29B	$53.58B	$54.52B	$58.99B	$56.43B	$55.72B	$58.53B	$59.02B	$56.28B	$49.36B	$51.41B
Total current liabilities	$11.28B	$13.02B	$10.78B	$11.72B	$12.00B	$12.34B	$11.19B	$12.30B	$11.81B	$9.48B	$11.02B	$12.00B
Short-term debt	$1.80B	$3.67B	$1.81B	$1.81B	$1.81B	$2.81B	$2.81B	$2.81B	$2.81B	$1.31B	$2.41B	$2.42B
Long-term debt	$23.19B	$21.53B	$21.54B	$21.44B	$24.90B	$22.15B	$22.14B	$22.14B	$22.13B	$20.86B	$23.83B	$23.82B
Total debt	$24.99B	$25.19B	$23.35B	$23.25B	$26.71B	$24.95B	$24.95B	$24.94B	$24.94B	$22.17B	$26.25B	$26.23B
Total liabilities	$39.29B	$38.75B	$35.30B	$36.05B	$39.66B	$37.27B	$36.05B	$36.99B	$36.32B	$32.76B	$37.53B	$38.37B
Shareholders' equity	$22.83B	$17.54B	$18.28B	$18.48B	$19.33B	$19.16B	$19.67B	$21.54B	$22.70B	$23.52B	$11.83B	$13.04B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$2.17B	$2.22B	$1.32B	$4.31B	$2.98B	$1.76B	$827.00M	$4.11B	$3.33B	$2.54B	$3.57B	$5.04B
Capital expenditures	$215.00M	$105.00M	$130.00M	$141.00M	$147.00M	$104.00M	$107.00M	$147.00M	$205.00M	$117.00M	$140.00M	$237.00M
Free cash flow	$1.95B	$2.11B	$1.20B	$4.17B	$2.83B	$1.65B	$720.00M	$3.96B	$3.12B	$2.43B	$3.43B	$4.80B
Investing cash flow	-$727.00M	-$2.21B	-$307.00M	-$710.00M	-$225.00M	-$415.00M	-$2.12B	-$427.00M	-$1.83B	$1.77B	-$10.35B	-$244.00M
Financing cash flow	-$1.10B	-$1.36B	-$2.95B	-$1.38B	$2.26B	-$3.43B	-$1.57B	-$1.49B	-$1.26B	-$4.24B	$2.34B	-$1.53B
Dividends paid	$943.00M	$990.00M	$972.00M	$983.00M	$973.00M	$1.01B	$994.00M	$1.00B	$994.00M	$1.04B	$1.03B	$1.04B
Share buybacks	$150.00M	$400.00M	$100.00M	$300.00M	$350.00M	$730.00M	$527.00M	$435.00M	$230.00M	$419.00M	$355.00M	$370.00M
Stock-based compensation	$201.00M	$187.00M	$210.00M	$216.00M	$222.00M	$209.00M	$225.00M	$230.00M	$230.00M	$218.00M	$231.00M	$234.00M
Depreciation & amortization	$91.00M	$94.00M	$98.00M	$94.00M	$95.00M	$97.00M	$93.00M	$90.00M	$90.00M	$93.00M	$98.00M	$132.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.